Showing results (71-80 of 242) with videos related to

Sort By:
Pageof 25
JCO Precision Oncology|July 6, 2026
Time to Treatment Failure as an End Point in Pragmatic Oncology Trials: Association With Progression-Free Survival Across Randomized StudiesJanene Dalrymple, Rebecca Symons, Katrin M Sjoquist, et al.
Clinical Colorectal Cancer|September 2, 2006
Addition of gabapentin to a modified FOLFOX regimen does not reduce oxaliplatin-induced neurotoxicityPaul L Mitchell, David Goldstein, Michael Michael, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 6, 2011
2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus ConferenceGavin C E Stuart, Henry Kitchener, Monica Bacon, et al.
European Journal of Cancer (Oxford, England : 1990)|June 23, 2009
Prevalence and predictors of insomnia in women with invasive ovarian cancer: anxiety a major factorMelanie A Price, Robert Zachariae, Phyllis N Butow, et al.
JCO Precision Oncology|January 11, 2024
Validity and Efficiency of Progression-Free Survival-2 as a Surrogate End Point for Overall Survival in Advanced Cancer Randomized TrialsRachel Woodford, Deborah Zhou, Peey-Sei Kok, et al.
The Oncologist|February 1, 2021
Weekly Paclitaxel-Induced Neurotoxicity in Breast Cancer: Outcomes and Dose ResponseHannah C Timmins, Tiffany Li, Terry Trinh, et al.
Journal of Medical Imaging and Radiation Oncology|March 4, 2016
Neoadjuvant chemoradiation (modified Eilber protocol) versus adjuvant radiotherapy in the treatment of extremity soft tissue sarcomaChris Lehane, Frederick Ho, Stephen R Thompson, et al.
JAMA Network Open|September 8, 2020
Validation of Progression-Free Survival Rate at 6 Months and Objective Response for Estimating Overall Survival in Immune Checkpoint Inhibitor Trials: A Systematic Review and Meta-analysisPeey-Sei Kok, Doah Cho, Won-Hee Yoon, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 5, 2010
Malignant transformation within ovarian dermoid cysts: an audit of treatment received and patient outcomes. an Australia New Zealand gynaecological oncology group (ANZGOG) and gynaecologic cancer intergroup (GCIG) studyM Corona Gainford, Anna Tinker, Jonathan Carter, et al.
Breast Cancer Research and Treatment|November 23, 2018
The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysisKirsty Wai Chung Lee, Sally Lord, Richard S Finn, et al.
Pageof 25